John M Akudugu1, Edouard I Azzam, Roger W Howell. 1. Division of Radiation Research, Department of Radiology, New Jersey Medical School Cancer Center, University of Medicine & Dentistry of New Jersey, Newark, New Jersey 07103, USA. jakudugu@sun.ac.za
Abstract
PURPOSE: This study uses a three-dimensional cell culture model to investigate lethal bystander effects in human breast cancer cell cultures (MCF-7, MDA-MB-231) treated with (125)I-labeled 5-iodo-2 -deoxyuridine ((125)IdU). These breast cancer cell lines respectively form metastatic xenografts in nude mice in an estrogen-dependent and independent manner. MATERIALS AND METHODS: In the present study, these cells were cultured in loosely-packed three-dimensional architecture in a Cytomatrix™ carbon scaffold. Cultures were pulse-labeled for 3 h with (125)IdU to selectively irradiate a minor fraction of cells, and simultaneously co-pulse-labeled with 0.04 mM 5-ethynyl-2'-deoxyuridine (EdU) to identify the radiolabeled cells using Click-iT(®) EdU and flow cytometry. The cultures were then washed and incubated for 48 h. The cells were then harvested, serially diluted, and seeded for colony formation. Aliquots of cells were subjected to flow cytometry to determine the percentage of cells labeled with (125)IdU/EdU. Additional aliquots were used to determine the mean (125)I activity per labeled cell. The percentage of labeled cells was about 15% and 10% for MCF-7 and MDA cells, respectively. This created irradiation conditions wherein the cross-dose to unlabeled cells was small relative to the self-dose to labeled cells. The surviving fraction relative to EdU-treated controls was measured. RESULTS: Survival curves indicated significant lethal bystander effect in MCF-7 cells, however, no significant lethal bystander effect was observed in MDA-MB-231 cells. CONCLUSIONS: These studies demonstrate the capacity of (125)IdU to induce lethal bystander effects in human breast cancer cells and suggest that the response depends on phenotype.
PURPOSE: This study uses a three-dimensional cell culture model to investigate lethal bystander effects in humanbreast cancer cell cultures (MCF-7, MDA-MB-231) treated with (125)I-labeled 5-iodo-2 -deoxyuridine ((125)IdU). These breast cancer cell lines respectively form metastatic xenografts in nude mice in an estrogen-dependent and independent manner. MATERIALS AND METHODS: In the present study, these cells were cultured in loosely-packed three-dimensional architecture in a Cytomatrix™ carbon scaffold. Cultures were pulse-labeled for 3 h with (125)IdU to selectively irradiate a minor fraction of cells, and simultaneously co-pulse-labeled with 0.04 mM 5-ethynyl-2'-deoxyuridine (EdU) to identify the radiolabeled cells using Click-iT(®) EdU and flow cytometry. The cultures were then washed and incubated for 48 h. The cells were then harvested, serially diluted, and seeded for colony formation. Aliquots of cells were subjected to flow cytometry to determine the percentage of cells labeled with (125)IdU/EdU. Additional aliquots were used to determine the mean (125)I activity per labeled cell. The percentage of labeled cells was about 15% and 10% for MCF-7 and MDA cells, respectively. This created irradiation conditions wherein the cross-dose to unlabeled cells was small relative to the self-dose to labeled cells. The surviving fraction relative to EdU-treated controls was measured. RESULTS: Survival curves indicated significant lethal bystander effect in MCF-7 cells, however, no significant lethal bystander effect was observed in MDA-MB-231 cells. CONCLUSIONS: These studies demonstrate the capacity of (125)IdU to induce lethal bystander effects in humanbreast cancer cells and suggest that the response depends on phenotype.
Authors: Suneil Jain; Jonathan A Coulter; Alan R Hounsell; Karl T Butterworth; Stephen J McMahon; Wendy B Hyland; Mark F Muir; Glenn R Dickson; Kevin M Prise; Fred J Currell; Joe M O'Sullivan; David G Hirst Journal: Int J Radiat Oncol Biol Phys Date: 2010-11-20 Impact factor: 7.038
Authors: G Petrovski; G Zahuczky; K Katona; G Vereb; W Martinet; Z Nemes; W Bursch; L Fésüs Journal: Cell Death Differ Date: 2007-03-16 Impact factor: 15.828
Authors: R W Howell; P V S V Neti; M Pinto; B I Gerashchenko; V R Narra; E I Azzam Journal: Radiat Prot Dosimetry Date: 2007-02-06 Impact factor: 0.972
Authors: Marion T Weigel; Linda Dahmke; Christian Schem; Dirk O Bauerschlag; Katrin Weber; Peter Niehoff; Maret Bauer; Alexander Strauss; Walter Jonat; Nicolai Maass; Christoph Mundhenke Journal: BMC Cancer Date: 2010-08-09 Impact factor: 4.430
Authors: Benjamin J Blyth; Edouard I Azzam; Roger W Howell; Rebecca J Ormsby; Alexander H Staudacher; Pamela J Sykes Journal: Radiat Res Date: 2010-02 Impact factor: 2.841
Authors: Calvin N Leung; Brian S Canter; Didier Rajon; Tom A Bäck; J Christopher Fritton; Edouard I Azzam; Roger W Howell Journal: J Nucl Med Date: 2019-09-13 Impact factor: 10.057
Authors: Narongchai Autsavapromporn; Sonia M De Toledo; Jean-Paul Jay-Gerin; Andrew L Harris; Edouard I Azzam Journal: J Radiat Res Date: 2012-11-08 Impact factor: 2.724
Authors: Didier A Rajon; Brian S Canter; Calvin N Leung; Tom A Bäck; J Christopher Fritton; Edouard I Azzam; Roger W Howell Journal: Int J Radiat Biol Date: 2021-07-26 Impact factor: 3.352